We report the solid-phase library construction of 222 number of a novel N-[alkyl sulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide 1A and amine 1B derivatives. The polymer-bound N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide 9 and amine 10 derivatives were obtained by first diversity generation with various acid chlorides and alkyl halides. Further reactions on the resins 9 and 10 with substituted sulfonyl chlorides produced the desired N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide 1A and amine 1B analogues.
Introduction
Heterocyclic compounds provide scaffolds on which pharmacophores can be arranged to yield potent and selective drugs, and a variety of heterocycles have been synthesized on solid support.
1 As a part of our research on drug discovery program, we needed to develop a facile and rapid solid-phase parallel synthesis for construction of the drug-like small molecules using heterocycles.
2 Especially, we were interested in constructing the variously substituted benzopyran library because of their broad biological activities.
3 Over several years, we have investigated many structural classes of 5-LO inhibitors with the aim of identifying orally active 5-LO (5-lipoxygenase) target as anti-inflammatory inhibitors. As the results, we found out a novel 6-amino-2,2-dimethyl-3,4,6-trisubstituted-2H-1-benzopyran hit compound (one representative lead compound is KRH-102140 with the 6-amino-2,2-dimethyl-3,4,6-trisubstituted-2H-1-benzopyran and showed good in vitro activity at 0.16 μm IC 50 value) 4a toward 5-LO target. 4 However, we didn't find out much improved hit compound by optimization process of KRH-102140 core skeleton derivatives. Therefore, our concern focused on the development of a spirobenzopyran core skeleton to improve more active benzopyran derivatives then the KRH-2140 as shown Figure 1 . As the results, herein, we report a solid-phase parallel synthesis of a novel N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide 1A and amine 1B derivatives that relies on BAL linker and present an chemical properties using a in silico screening.
Results and Discussion
As shown in the Scheme 1, the strategy we have developed, backbone amide linker (BAL) resin 5 2 was selected as the polymer support since the secondary amino group, resulting from reductive amination, should be highly reactive with various alkyl halides and acid chlorides. Moreover, the final products should be readily cleaved from the support by using dilute TFA solutions. 6 In the first step of the sequence, N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]amine resin 4 was prepared by reaction of BAL resin 2 with N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]amine 7 3 under reductive amination conditions (NaBH(OAc) 3 in DMF containing 1% acetic acid). 8 The success of this process was confirmed by the disappearance of the aldehyde carbonyl band in the ATR-FTIR (Attanuated Total Reflection-FTIR) spectrum at 1677 cm −1 and the appearance of the carbamate band at 1694 cm −1 . In the first generation diversification step, the secondary 
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Bull. Korean Chem. Soc. 2012, Vol. 33, No. 1 129 amine group in N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]amine resin 4 was transformed into the 6-substituted amide and amine groups in N-[ethylcarbamatespiro(2H-1-benzopyran-2,4-piperidine)-6-yl]substituted amide resin 5 or amine resin 6 by reactions with acid chlorides or alkyl halides in the presence of DBU (1,8-diazabicylclo[5,4,0] undec-7ene) or LiO t Bu (litium-tertbutoxide) in DMF solution, respectively. The progress of these reactions was assessed by the appearance of characteristic bands in the ATR-FTIR spectrum (amide 5: 1650 cm −1 , amine 6: disappearance NH band about 3200 cm −1 ). For the purpose of second generation diversity, the carbamate deprotection of the 6-substituted amide resin 5 and the 6-substituted amine resin 6 were carried out to yield the piperidines 5 and 6 by hydrolysis reaction by hydrolysis reaction in the presence of NaOH under the condition of nbutanol and 1,4-dioxane mixture solvent at room temperature. And then, functionalization of the secondary piperidine amine group on the resins 7 and 8 were promoted by reactions with various sulfonyl chlorides to generate respective N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide resin 9 and substituted amine resin 10 in the presence of Et 3 N in DMF. Finally, the resins 9 and 10 were treated with 20% TFA in CH 2 Cl 2 for 3 h to yield the desired drug-like N-[alkylsulfonamidospiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide 1A and amine 1B derivatives. The five-step overall yields was shown in Table 1 and 2. In the Table 1 , our concern focused on the introduction of various amide substituents R 1 groups on the 6-amine position of N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]amine resin 4 with acid chlorides, such as electron donating group 1A2, withdrawing group 1A3. And also, we have successful proceeded various sulfonyl substituents R 3 groups on the 6-substituted amide resin 7 with various sulfonyl chlorides. Finally, we could obtained the desired drug-like N-[alkyl sulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide derivatives 1A from the 6-substituted amide resin 9 with high five-step overall yields. Next, as shown in the Table 2 , we tried to find out good reaction condition to introduce amine substituents R 2 on the 6-position of N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]amine resin 4. The LiO t Bu base condition gave to the substituted amine derivatives, such as alkyl or benzyl functional groups on the N-[ethylcarbamate-spiro-(2H-1-benzopyran-2,4-piperidine)-6-yl]amine resin 4 with various alkyl halides.
The introduction of sulfonyl groups into the secondary piperidine amine group on resin 8 was proceeded under mild base condition after deprotection of the carbamate-protected Table 1 . Five-step overall yield from the resin 2 (loading capacity of the resin 2 is 0.5 mmol/g). 
Five-step overall yield from the resin 2 (loading capacity of the resin 2 is 0.5 mmol/g).
resin 6. And the cleavage of the N-[alkylsulfonamido-spiro-(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amine resin 10 gave the desired drug-like N-[alkylsulfonamidospiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amine derivatives 1B under same reaction condition of the amide generation reaction 1A. At this point, our effort was focused on the generation of fluorine substituent as R 1 , R 2 and R 3 groups since the most of fluorine substituted derivatives appeared to show much higher inhibition activity toward 5-LO (5-lipoxygenase) in cell base assay. The effort described above has led to the development of a novel solid-phase parallel synthetic strategy for the preparation of a broad N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide 1A and amine 1B libraries. Having established a flexible method for solid phase synthesis of N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide and amine derivatives, our attention next turned to the evaluation of the potential drug properties of members of this family. In general, the goal of a drug discovery process is to synthesize chemical entities which are orally bioavailable; i.e. they possess physiological properties that allow them to be absorbed into the gastrointestinal system. Lipinski's Rule 10 and similar formulations 11 served as guidelines for an estimation of the physicochemical properties of the synthesized 222 member N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amide 1A and amine 1B library, which was calculated using Accord for Excel functions. 12 Of particular interest were the key bioavailability parameters such as molecular weight, lipophilicity, number of hydrogen bond donors and acceptors, number of rotatable bonds, and polar surface area. Chart 1 are shown the results of these bioavailability calculations, performed on the library we have constructed. As can be seen by viewing the data, all of the key parameters for members of the constructed library fall in the range of those predicted values for reasonable drugs by using the commonly known Lipinski's rule of 5.
In summary, we constructed of 222 number of a novel N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)- 6-yl] substituted amide 1A and amine 1B derivatives by solid-phase parallel synthesis with high five-step overall yields. The primary biological tests toward 5-LO targets were conducted to develop anti-inflammatory inhibitors. And then we found out several good hit compounds for 5-LO inhibitors, which result was applied to the Korean patent. 9 In the next plan, the selected hit N-[alkylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] substituted amine 1B compounds will be subjected to in vivo and pharmacology analysis for the development of a novel anti-inflammatory drugs underlying the 5-LO mechanistic target to discovery new anti-inflammatory drug.
Experimental Section
General Procedures. All chemicals were reagent grade and used as purchased. Reactions were monitored by TLC analysis using Merck silica gel 60 F-254 thin layer plates. Flash column chromatography was carried out on Merck silica gel 60 (230-400 mesh). The crude products were purified by parallel chromatography using Quad3
H NMR spectra were recorded in d units relative to deuterated solvent as an internal reference using a Bruker 300 or 500 MHz NMR instrument. LC-MS analysis was performed on an ESI mass spectrometer with PDA detection. LC-MS area % purities of all products were determined by LC peak area analysis (XTerraMS C 18 column, 4.6 mm × 100 mm; PDA detector at 200-400 nm; gradient, 5-95% CH 3 CN/H 2 O).
Preparation of Key Intermediate Polymer-bound N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]amine 4. To a suspension of BAL resin 2 (1.0 g, 0.5 mmol, loading capacity 0.5 mmol/g) in DMF (10 mL) containing 1% acetic acid were added successively N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] amine 3 (0.47 mg, 1.6 mmol) and NaBH(OAc) 3 (0.34 g, 1.6 mmol). The suspension was shaken for 24 h at room temperature under N 2 gas. The suspension was filtered and the precipitate containing the N-[ethylcarbamate-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] amine resin 4 was washed with DMF (× 2), DCM (× 2), and MeOH (× 2), and dried under high vacuum. FTIR (cm Step, Formation of the N-[1'-methyl sulfonamido-spiro-(2H-1-benzopyran-2,4-piperidine)-6-yl]-2-fluorophenyl Amide Resin 5A1. To a suspension of resin 4 (1.0 g, 0.5 mmol, loading capacity 0.5 mmol/g) in DMF were added 2-flurobezoyl chloride (237.8 mg, 1.5 mmol) and DBU (228.4 mg, 1.5 mmol) with cat. DMAP. The suspension was shaken for 24 h at 40 o C under N 2 gas. The suspension was filtered and the precipitate containing the 6-(2-fluorophenyl) amide resin 5A1 was washed with DMF (× 2), DCM (× 2), and MeOH (× 2), and dried under high vacuum.
Representative Procedure for the Carbamate Deprotection Step, Formation of the 6-(2-fluorophenyl) Amide Resin 7A1. To a suspension of resin 5A1 (1.0 g, 0.5 mmol, loading capacity 0.5 mmol/g) in n-butanol and 1,4-dioxane (1:3) mixture solvent were added NaOH (100 mg, 2.5 mmol). The suspension was shaken for 8 h at room temperature. The suspension was filtered and the precipitate containing 6-(2-fluorophenyl)amide carbamate deprotected resin 7A1 was washed with DMF (× 2), DCM (× 2), and MeOH (× 2), and dried under high vacuum.
Representative Procedure for the Second Diversification Step, Formation of the N-methyl sulfonyl-6-(2-fluorophenyl) Amide Resin 9A1. To a suspension of resin 7A1 (1.0 g, 0.5 mmol, loading capacity 0.5 mmol/g) in DMF solvent were added methyl sulfonyl chloride (171.8 mg, 1.5 mmol) and Et 3 N (506.0 mg, 2.5 mmol). The suspension was shaken for 12 h at room temperature. The suspension was filtered and the precipitate containing N-methanesulfonyl-6-(2-fluorophenyl) amide resin 9A1 was washed with DMF (× 2), DCM (× 2), and MeOH (× 2), and dried under high vacuum.
Representative Procedure for Cleavage of Resin 9A1, Preparation of N-[methyl sulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]-2-fluorophenyl Amide 1A1. N-methanesulfonyl-6-(2-fluorophenyl) amide resin 9A1 (200 mg, 0.1 mmol) was treated with 2 mL 1:4 TFA/DCM. After being shaken at room temperature for 3 h, the mixture was filtered and the precipitate containing resin washed with DCM (3 mL × 2). The combined filtrates were concentrated in vacuous to yield N-[1'-methane sulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]-2-fluorophenyl amide 1A1 (10.4 mg, five-step overall yields, 47%) as an oil. H NMR (500 MHz, CDCl 3 ) δ 8.34 (d, 2H, J = 8.7 Hz), 8.01 (d, 2H, J = 8.7 Hz), 7.67 (dd, 1H, J = 5.0 Hz, J = 1.3 Hz), 7.59 (dd, 1H, J = 3.8 Hz, J = 1.3 Hz), 7.36 (d, 1H, J = 2.5 Hz), 7.26 (dd, 1H, J = 8.6 Hz, J = 2.5 Hz), 7.20 (dd, 1H, J = 5.0 Hz, J = 3.8 Hz), 6.69 (d, 1H, J = 8.6 Hz), 6.41 (d, 1H, J = 9.8 Hz), 5.58 (d, 1H, J = 9.8 Hz), 2H) , 2.93-2.88 (m, 2H), 2.14-2.11 (m, 2H), 1.85-1.82 (m, 2H) .
Representative Procedure for the First Diversification Step, Formation of the N-[4-fluorophenylsulfonamidospiro(2H-1-benzopyran-2,4-piperidine)-6-yl] Benzyl Amine Resin 6B1. To a suspension of resin 4 (1.0 g, 0.5 mmol, loading capacity 0.5 mmol/g) in DMF were added benzyl chloride (189.9 mg, 1.5 mmol) and LiO t Bu (120.7 mg, 1.5 mmol). The suspension was shaken for 24 h at 40 o C under N 2 gas. The suspension was filtered and the precipitate containing the 6-benzyl substituted amine resin 6B1 was washed with DMF (× 2), DCM (× 2), and MeOH (× 2), and dried under high vacuum.
Representative Procedure for the Carbamate Deprotection Step, Formation of the 6-Benzyl Substituted Amine Piperidine Carbamate Deprotected Resin 8B1. To a suspension of resin 6B1 (1.0 g, 0.5 mmol, loading capacity 0.5 mmol/g) in n-butanol and 1,4-dioxane (1:3) mixture solvent were added NaOH (100 mg, 2.5 mmol). The suspension was shaken for 8 h at room temperature. The suspension was filtered and the precipitate containing 6-benzyl amine carbamate deprotected resin 8B1 was washed with DMF (× 2), DCM (× 2), and MeOH (× 2), and dried under high vacuum.
Representative Procedure for the Second Diversification Step, Formation of the Spiro-N-(4-fluorophenyl)-sulfonamido-6-benzyl amine resin 10B1. To a suspension of resin 8B1 (1.0 g, 0.5 mmol, loading capacity 0.5 mmol/g) in DMF solvent were added methyl sulfonyl chloride (171.8 mg, 1.5 mmol) and Et 3 N (506.0 mg, 2.5 mmol). The suspension was shaken for 12 h at room temperature. The suspension was filtered and the precipitate containing N-(4-fluorophenyl)sulfonamido-6-benzyl amine resin 10B1 was washed with DMF (× 2), DCM (× 2), and MeOH (× 2), and dried under high vacuum.
Representative Procedure for Cleavage of Resin 10B1, Preparation of N-[4-Fluorophenyl sulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl] benzyl amine 1B1. N-4-fluorophenyl sulfonamido-6-substituted benzyl amide resin 10B1 (200 mg, 0.1 mmol) was treated with 2 mL 1:4 TFA/DCM. After being shaken at room temperature for 3 h, the mixture was filtered and the precipitate containing resin washed with DCM (3 mL × 2). The combined filtrates were concentrated in vacuo to yield N-[4-fluorophenylsulfonamido-spiro(2H-1-benzopyran-2,4-piperidine)-6-yl]-benzyl amine 1B1 (10.4 mg, five-step overall yields, 34%) as an oil. 4.44 (s, 2H), 3.58-3.55 (m, 
